Morgan Stilgenbauer is a Senior Scientist in Investigative Toxicology at Tessera with a PhD from Kent State University. Her expertise is in oncology drug development, focusing on targeted protein degradation for previously "undruggable" targets. Colleagues have described her as an inquisitive scientist and a major contributor to her programs.
Her graduate research involved synthesizing novel Platinum(IV) prodrugs designed to target and overcome drug resistance in ovarian cancer stem cells.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.